Association of ablation of Barrett's esophagus with high grade dysplasia and adenocarcinoma of the gastric cardia

Diseases of the Esophagus

Volumn 19, Issue 4, 2006, Pages 277-279

  Sampliner, Richard E ^a   Camargo, E ^a   Prasad, A R ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Ablation; Adenocarcinoma; Barrett's esophagus; Gastric cardia; High grade dysplasia

Indexed keywords

PROTON PUMP INHIBITOR;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CARDIA CARCINOMA; CASE REPORT; CELL PROLIFERATION; DYSPLASIA; ENDOSCOPIC BIOPSY; ENDOSCOPIC THERAPY; FEMALE; GENE MUTATION; HUMAN; INTESTINE METAPLASIA; MALE; PRIORITY JOURNAL;

ADENOCARCINOMA; AGED; BARRETT ESOPHAGUS; CARDIA; CATHETER ABLATION; ESOPHAGOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; STOMACH NEOPLASMS;

EID: 33745852740     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2006.00577.x     Document Type: Article

References (15)

1. Schnell T G, Sontag S J, Chejfec G et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001; 120: 1607-19.
2. Sampliner R E. Practice Parameters Committee ACG. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002; 97: 1888-95.
3. Begg C B, Cramer L D, Hoskins W J, Brennan M F. Impact of hospital volume on operative mortality for major cancer surgery. JAMA 1998; 280: 1747-51.
4. Overholt B, Lightdale C, Wang K et al. International, multicenter, partially blinded, randomised study of the efficacy of photodynamic therapy (PDT) using porfimer sodium (POR) for the ablation of high-grade dysplasia (HGD) in Barrett's esophagus (BE): Results of 24-month follow-up. Gastroenterology 2003; 124: A20.
5. Krishnadath K K, Wang K K, Taniguchi K et al. Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy. Gastroenterology 2000; 119: 624-30.
6. McClave S A, Boyce H W, Gottfried M R. Early diagnosis of columnar lined esophagus: A new endoscopic diagnostic criterion. Gastrointestinal Endoscopy 1987; 33: 413 -16.
7. Reid B J, Blount P, Feng Z, Levine D. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. Am J Gastroenterol 2000; 95: 3089-96.
8. Tseng E E, Wu T T, Yeo C F, Heitmiller R F. Barrett's esophagus with high grade dysplasia. surgical results and long-term outcome - an update. J Gastrointest Surg 2003; 7: 164-71.
9. Clark G W, Smyrk T C, Burdiles P, Hoeft S F, Peters J H. Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg 1994; 129: 609-14.
10. Cameron A J, Lomboy C T, Pera M et al. Adenocarcinoma of the esophagastric junction in Barrett's esophagus. Gastroenterology 1995; 109: 1541-6.
11. Overholt B F, Panjehpour M, Halberg D L. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early carcinoma: Long-term results. Gastrointest Endosc 2003; 58: 183-8.
12. Garewal H S, Ramsey L, Sharma P, Kraus K, Sampliner R E, Fass R. Biomarker studies in reversed Barrett's esophagus. Am J Gastroenterol 1999; 94: 2829-33.
13. Weston A P, Sharma P, Topalovski M. Cardia post-Barrett's ablation: An unrecognized source of concern (Abstract). Am J Gastroenterol 2001; 96: 577 (248).
14. Sampliner R E. Detecting, measuring, and managing Barrett's esophagus - the complete endoscopist. Gastrointest Endosc 1997; 45: 533-5.
15. Boyce H W. Barrett's Esophagus. J Clin Gastroenterol 2003; 36: S6-S18.